These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7875160)

  • 41. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
    J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.
    Sasco AJ; Chaplain G; Amoros E; Saez S
    Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uterine neoplasms in patients treated with tamoxifen.
    Silva EG; Tornos C; Malpica A; Mitchell MF
    J Cell Biochem Suppl; 1995; 23():179-83. PubMed ID: 8747394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endometrial lesions after tamoxifen therapy in breast cancer women.
    Maugeri G; Nardo LG; Campione C; Nardo F
    Breast J; 2001; 7(4):240-4. PubMed ID: 11678801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
    Sinawat S; Chiyabutra T; Kleabkaew P
    Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cohen I; Altaras MM; Tepper R; Beyth Y
    Gynecol Oncol; 1996 Dec; 63(3):412-4. PubMed ID: 8946882
    [No Abstract]   [Full Text] [Related]  

  • 50. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P; Fawzi H
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract]   [Full Text] [Related]  

  • 51. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
    Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
    Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
    Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postmenopausal tamoxifen treatment and endometrial pathology.
    Cohen I; Altaras MM; Shapira J; Tepper R; Beyth Y
    Obstet Gynecol Surv; 1994 Dec; 49(12):823-9. PubMed ID: 7885659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.
    Biron-Shental T; Tepper R; Fishman A; Shapira J; Cohen I
    Gynecol Oncol; 2003 Aug; 90(2):382-6. PubMed ID: 12893204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controversies regarding tamoxifen and uterine carcinoma.
    Neven P; Vergote I
    Curr Opin Obstet Gynecol; 1998 Feb; 10(1):9-14. PubMed ID: 9484623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
    Reslová T; Tosner J; Vávrová I; Resl M
    Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen-induced endometrial cancer.
    Chen P; Yang CC; Chen YJ; Wang PH
    Eur J Gynaecol Oncol; 2003; 24(2):135-7. PubMed ID: 12701962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Jordan VC; Morrow M
    J Natl Cancer Inst; 2003 May; 95(9):683-4; author reply 684-5. PubMed ID: 12734320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.